NCT04189900View on ClinicalTrials.gov

Generation of Biological Samples Positive to Triptorelin for Anti-doping Control

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

April 26, 2019

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

Triptorelin

Subjects receive a single subcutaneous dose of 0,1 mg of Triptorelin acetate.

Trial Locations (1)

08003

IMIM (Hospital del Mar Medical Research Institute), Barcelona

All Listed Sponsors
lead

Parc de Salut Mar

OTHER

NCT04189900 - Generation of Biological Samples Positive to Triptorelin for Anti-doping Control | Biotech Hunter | Biotech Hunter